02591.HK
Guangzhou Innogen Pharmaceutl Grp Co Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 3.40
+3.98%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 15.32x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.36x
- Price / sales
- 8.47x
- Price / cash flow
- -3.72x
Enterprise value
- Enterprise value
- HKD 478.5M
- EV / sales
- 2.70x
- EV / EBITDA
- -1.28x
- EV / EBIT
- -1.23x
- Market cap
- HKD 1.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026